Post-Doctoral Fellow Opportunity
Job Description:
The Moslehi Laboratory at UCSF is seeking highly motivated candidates to be Post-Doctoral Fellow. The successful applicant will hold a Ph.D. and/or M.D. with experience in molecular biology, biochemistry, or immunology and have expertise in animal models. The ability to work independently and cooperatively within a team of clinicians and scientists is essential. Salary is dependent upon the applicant’s experience and follows NIH guidelines.
This position is specifically tailored to an applicant with a strong immunology background. The Moslehi laboratory has an interest in fundamental interactions between the immune and cardiovascular systems. This interest has been partly motivated by the laboratory’s previous work in identifying clinical syndromes of immune-checkpoint inhibitor (ICI)-associated cardiovascular toxicities which include myocarditis, pericarditis and vasculitis (Johnson et al, NEJM, 2016. Moslehi et al, Lancet, 2018. Salem et al, Lancet Oncology, 2018). We have created pre-clinical models for ICI-associated myocarditis including pharmacologically treated and genetic mouse models (Wei et al, Cancer Discovery, 2021). The preliminary data from the laboratory suggest a critical role of immune checkpoint (specifically PD-1 and PD-L1) in cardiac homeostasis and human cardiovascular disease, a hypothesis that is currently being tested in the laboratory.
Requirements
Ph.D. in genetics, molecular biology, cell biology, immunology, or related field.
Skills in molecular biology techniques including single-cell RNA sequencing, data analysis
Enthusiastic, self-motivated, and able to actively lead complex translational projects.
Excellent written and oral communication skills.
To apply
Please forward CV to Dr. Javid Moslehi at: [email protected]
Contact information for 3 reference
About UCSF Section of Cardio-Oncology & Immunology
The UCSF section of cardio-oncology program is interested in cardio-oncology and cardio-oncology, and integrates basic and translational scientists and clinicians. It is a premier program in the world. For more information: